# Hemal Somaiya

> Hemal Somaiya is a PharmaForceIQ co-founder and its Chief Executive and Strategy Officer. Her career includes strategy consulting at IMS Consulting Group, now IQVIA, and marketing leadership roles at Merck, AstraZeneca and Boston Scientific. Her public work focuses on customer engagement, coordinated execution and data-informed marketing decisions.

- **Role:** Co-founder; Chief Executive and Strategy Officer at PharmaForceIQ
- **Organizations:** PharmaForceIQ, Merck KGaA / EMD Serono, AstraZeneca, Boston Scientific, IMS Consulting Group / IQVIA
- **Education:** Executive MBA in Entrepreneurship and Innovation, MIT Sloan School of Management, MBA in Business and Clinical Regulatory Affairs, Claremont Graduate University
- **Known for:** Co-founder of PharmaForceIQ., Selected for the 2025 MM+M Women of Distinction class., Named a Disrupter in the 2025 PM360 ELITE 100.

## Career timeline

- **2021** — Identified as US/Global Brand Lead at Merck KGaA in an October Life Science Marketing Radio appearance.
- **2022** — Published a Forbes Business Council article on omnichannel marketing; council profile identifies her as Head of Omnichannel Marketing at PharmaForceIQ.
- **2024** — Named Head of Omnichannel in PharmaForceIQ's announcement of a majority investment from Eir Partners.
- **2025** — Identified as Chief Strategy Officer; received MM+M Women of Distinction and PM360 ELITE 100 Disrupter recognition.
- **2026** — Identified as Chief Executive and Strategy Officer in the January Aktana acquisition announcement and subsequent publications.

## Achievements

- Co-founder of PharmaForceIQ.
- Selected for the 2025 MM+M Women of Distinction class.
- Named a Disrupter in the 2025 PM360 ELITE 100.

## Latest updates

- **2026-10** — Published an October 12 Pharmaceutical Commerce article on precision marketing and share of answer.
- **2026-09** — Published a PM360 article arguing for selective channel use and closer field-marketing coordination.
- **2026-04** — PharmaForceIQ highlighted her joint World Pharma Today interview with Derek Choy.
- **2026-01** — Commented as Chief Executive and Strategy Officer on PharmaForceIQ's acquisition of Aktana, announced January 7.

## Links

- Website: https://pharmaforceiq.com/
- LinkedIn: https://www.linkedin.com/in/hemalsomaiya/

---

Profile page: https://yespress.io/hemal-somaiya
Published by YesPress — https://yespress.io
Last updated: 2026-10-27